Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study

Autor: Choueiri, Toni K *, McDermott, David F, Merchan, Jaime, Bauer, Todd M, Figlin, Robert, Heath, Elisabeth I, Michaelson, M Dror, Arrowsmith, Edward, D'Souza, Anishka, Zhao, Song, Roy, Ananya, Perini, Rodolfo, Vickery, Donna, Tykodi, Scott S
Zdroj: In The Lancet Oncology May 2023 24(5):553-562
Databáze: ScienceDirect